Karolinska Institutet, Department of Laboratory Medicine
Ph.D (Molecular Cell Biology)
2002 - 2007
Karolinska institutet
Ph.D (Gene Therapy)
2001 - 2007
Stockholm School of Economics, Royal Institute of Technology
M.Sc.Eng; M.Sc.Eng (Economics and Entrepreneurship)
2004 - 2004
Uppsala Univeristy
M.Sc (Molecular Biotechnology)
1999 - 2002
Luleå tekniska universitet
Master of Science (M.Sc.) (Industrial Chemistry)
1995 - 1997
Finnvedens gymnasium
highschool (Teknikvetenskap)
1992 - 1995
Mathias Svahn's Skills
Molecular Biology
Biotechnology
Clinical Trials
Cell Biology
Lifesciences
Immunology
Research
GCP
Clinical Research
Stem Cells
Mathias Svahn's Summary
Mathias Svahn, based in Stockholm, SE, is currently a CEO at NextCell Pharma AB, bringing experience from previous roles at Cellaviva, FamiCordTx and Karolinska Institutet. Mathias Svahn holds a 2002 - 2007 Ph.D in Molecular Cell Biology @ Karolinska Institutet, Department of Laboratory Medicine. With a robust skill set that includes Molecular Biology, Biotechnology, Clinical Trials, Cell Biology, Lifesciences and more, Mathias Svahn contributes valuable insights to the industry. Mathias Svahn has 2 emails on RocketReach.